Sat.Oct 17, 2020 - Fri.Oct 23, 2020

article thumbnail

UK trials digital ‘health passport’ to help borders reopen

pharmaphorum

Regular fliers are used to long queues to clear security – but a rigorous COVID-19 testing regime could be added to pre-flight checks backed by a digital “health passport” to prove passengers are free from the coronavirus. The UK is the latest country to test the scheme that allows passengers to demonstrate their coronavirus status as part of a global framework for COVID-safe air travel.

Vaccines 140
article thumbnail

WHO: remdesivir shows little effect on COVID-19

Outsourcing Pharma

The agencyâs Solidarity Therapeutics Trial examined a range of drugs repurposed for COVID-19 treatment, finding nearly no effect on patient mortality.

120
120
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Best Toenail Fungus Treatment Products

Druggist

Fungal nail infection is a common condition, which usually affects toenails. The main products used for toenail fungus treatment are available in most pharmacies, supermarkets and perhaps with the best range of products found online. Topical products, which are applied directly to the infected area, are the main products used as toenail fungus treatment.

98
article thumbnail

Using Behavioral Science in A Digital World

Pharma Mirror

By Rotem Shor, Medisafe Chief Technology Officer Technology and health have experienced a convergence in the last few years, leading to a new state of digital health that is transforming how we live and work. But there is a greater science behind it that analyzes tremendous amounts of data to shape and personalize our health. The post Using Behavioral Science in A Digital World appeared first on Pharma Mirror Magazine.

80
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Toxic positivity and grief: The reality of living through cancer

pharmaphorum

Cancer doesn’t end when treatment stops – it’s a lifelong journey and people need support throughout, says patient advocate Megan-Claire Chase. No one gets through cancer unscathed. People are usually left with a mixture of treatment aftereffects, toxic positivity, and lingering anger to deal with. Megan-Claire Chase , a fierce patient advocate who has been blogging about her experiences since she was diagnosed with breast cancer in 2015, said the disease never went away.

article thumbnail

FHI Clinical, Oracle partner on cloud-based trial tech

Outsourcing Pharma

The CRO and life-sciences tech firm collaborated on a solution capable of meeting challenges tied to starting and conducting global clinical trials.

83

More Trending

article thumbnail

CPhI Worldwide to return in 2021: Milan venue to play host to global pharma

Pharma Mirror

2021 will bring global pharma community back together in person to drive business growth CPhI Worldwide (31 August – 2 September 2021) will be held next year in Milan (Fiera Milano) for the first time in over a decade – following its postponement in 2020. The event returns at an apt moment, as the pharma industry in. The post CPhI Worldwide to return in 2021: Milan venue to play host to global pharma appeared first on Pharma Mirror Magazine.

52
article thumbnail

Novartis launches digital health hub in Canada

pharmaphorum

Novartis is opening a new digital health innovation hub in Canada to help develop “scalable, digital solutions” for patients and healthcare providers. The Canadian Biome Digital Innovation Hub will be based in Montreal at the artificial intelligence research institute, Mila. The institute formed a strategic alliance with Novartis in 2019. Canada is the latest country to join a global network of hubs opened by Novartis.

128
128
article thumbnail

COVID-19 response makes NZ an appealing trial destination

Outsourcing Pharma

A leader from a New Zealand-based CRO talks about the countryâs handling of the pandemic, and how their low rates are making sponsors take notice.

82
article thumbnail

What Do You Appreciate About Your Pharmacy Technicians?

indispensable health

To celebrate Pharmacy Technician Day we asked a few of our Pharmacists and Pharmacy Managers to tell us what they appreciate about the Pharmacy Technicians they work with. Pat | Pharmacist Pat, one of our Indispensable Health retail pharmacists, described how she loves how one of her technicians, in particular, takes her job really seriously and is conscientious of doing the best job possible.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

COVID-19 biologics will put huge pressure on large-scale bioprocessing networks

Pharma Mirror

Tightening of bio-manufacturing capacity expected to occur after 2024, whilst Europe forecast to equal North America in total capacity Amsterdam: The third part of the 2020 CPhI Annual Report – released during the second week of the CPhI Festival of Pharma (5-16 October, 2020) – predicts, that if approved, COVID vaccines and therapeutics will cause an impending biomanufacturing capacity.

article thumbnail

How real human experiences can power a healthier future

pharmaphorum

As part of our series of opinion pieces from leaders at Janssen, the company’s Maria Raad looks at how we can embrace tech and data science to overcome increasing pressures on healthcare systems. For the next generation born in the western world, living to be 100 will be the norm. While this seems like a desirable aspiration for our grandchildren, it adds new pressures on our healthcare systems.

article thumbnail

WuXi AppTec: think ahead when dual-filing IND applications

Outsourcing Pharma

A leader from the company advises planning ahead when filing investigational new drug applications to avoid wasting time, work and money later.

77
article thumbnail

2021 BCPS Exam – Developing A Plan and FAQ’s

Med Ed 101

Preparing for the BCPS exam is stressful. There’s a bit of added stress and mystery for those looking into the 2021 BCPS Exam. The content outline changed in the second half of 2020 and so the exam going forward may be slightly different than in previous years. I discussed those BCPS content outline changes previously […]. The post 2021 BCPS Exam – Developing A Plan and FAQ’s appeared first on Med Ed 101.

40
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

New research highlights Northern Ireland’s ‘thriving’ life sciences sector

Pharma Times

Pharmaceutical and life sciences industries are growing in importance across country

55
article thumbnail

Kite cues up first EMA okay for mantle cell lymphoma CAR-T

pharmaphorum

Gilead Sciences’ Kite Pharma unit is closing on approval of its second European approval for a CAR-T for cancer, after the CHMP backed its Tecartus therapy for mantle cell lymphoma. The EMA’s human drugs advisory committee recommended approval of Tecartus (brexucabtagene autoleucel; formerly KTE-X19 ) for relapsed or refractory MCL setting up a formal approval by the regulator in the coming weeks.

article thumbnail

Global Genes forges rare-disease support network partnership

Outsourcing Pharma

The rare-disease organization will work with Rady Childrenâs Institute for Genomic Medicine to help patients and their families connect with solutions.

61
article thumbnail

Sodium Chloride Supplements – Alarm Order for SIADH

Med Ed 101

Here’s a case scenario where sodium chloride supplements were added, and why I think it is important to recognize what that may mean. KD is a 63-year-old female with a history of bipolar disorder with depressive episodes, GERD, trigeminal neuralgia, constipation, hypertension, and edema. Current medications include omeprazole, sertraline, sucralfate, carbamazepine, lisinopril, hydrochlorothiazide, and docusate. […].

40
article thumbnail

UCB acquires new campus to support UK operations

Pharma Times

Following completion of acquisition, site will undergo refurbishment

55
article thumbnail

On-skin printing of sensors could monitor COVID-19 symptoms

pharmaphorum

Scientists say on-skin printing could be used to create on-body sensors to monitor physiological signals and devices to wirelessly transmit the data. A team led by Huanyu Cheng from Penn State University, say the sensors are capable of precisely and continuously capturing temperature, humidity, blood oxygen levels and heart performance signals. The next stage on the project is to target specific application, for example to develop a sensor network that could monitor symptoms associated with COVI

105
105
article thumbnail

BBK Worldwide survey reveals patients want trial innovation

Outsourcing Pharma

The latest iteration of BBK Worldwide's Study Voices survey reveals thoughts on decentralized studies, telehealth and other trial technology.

63
article thumbnail

Mixing Branded and Unbranded on One Page—Is it Worth the Risk?

Pharma Marketing Network

A marketer’s decision to take one promotional route over another—branded versus unbranded—is often critical. But what we increasingly see, is that when branded and unbranded ads appear on the same page—a company page on Facebook, a third-party web publisher, a blogger, etc.—the ads can come from different sources and that can lead to run ins with the FDA.

Labelling 104
article thumbnail

ABPI chief exec says no-deal Brexit is ‘not in the interest of patients’

Pharma Times

Chief executive of trade body warns no-deal could affect medicines supply

50
article thumbnail

COVID-19 ventilator demand fuels Philips Q3 sales

pharmaphorum

Huge demand for ventilators and patient monitors spurred third quarter sales for Royal Philips, the company announced. The Dutch health technology group reported sales of €4.98bn, a 10% year-over-year growth. The connected care business, which includes patient monitors and ventilators saw the biggest rise, increasing by 42%. Philips said it had ramped up production of the equipment to meet global demand.

Hospitals 102
article thumbnail

Sandoz incorporates RFID technology on injectables

Outsourcing Pharma

The generic drug manufacturer is working with Kit Check to incorporate the company's drug supply-chain management technology into two of its products.

59
article thumbnail

Lovima – Over the Counter Contraceptive

Druggist

Lovima (desogestrel) is the first daily oral contraceptive which is going to be available over the counter without a prescription. In the UK, all contraceptive are prescription-only medicines which require a doctor or other qualified prescriber to issue a prescription. Lovima is the first oral contraceptive which has a status or pharmacy-only medicine (P).

94
article thumbnail

FDA accepts review for ANGLE’s Parsortix system for metastatic breast cancer

Pharma Times

System captures and harvests intact circulating tumour cells for analysis

FDA 47
article thumbnail

Sarepta helps bankroll new gene therapy startup AavantiBio

pharmaphorum

Sarepta chief commercial officer Bo Cumbo has left to head up gene therapy venture – AavantiBio – with $107 million in backing from his former employer and three high-profile life sciences investors. Rare disease specialist Sarepta is putting up $15 million of that first-round financing, with the remainder coming from Perceptive Advisors, Bain Capital Life Sciences, and RA Capital Management.

FDA 98
article thumbnail

NIH kicks off COVID-19 immune modulator trial

Outsourcing Pharma

The US agency has launched a large clinical trial to examine the viability of using immune modulators to treat patients hospitalized with COVID-19.

article thumbnail

UK government signs contract for COVID-19 challenge trial

pharmaphorum

The UK government has signed a contract to develop a controversial COVID-19 human challenge trial, where participants will be deliberately infected in a controlled environment with coronavirus to test whether a vaccine is effective. Contract research organisation (CRO) hVIVO, a subsidiary of Open Orphan, has signed the contract with the UK government to develop the trial model.

article thumbnail

Novartis’ big bet on inclisiran nears fruition, as CHMP backs drug

pharmaphorum

Novartis’ near-$10 billion takeover of The Medicines Company last year was focused mainly on one asset – cholesterol-lowering drug inclisiran – and the Swiss pharma is now a step closer to getting a return on its investment. Inclisiran – now given the trade name Leqvio – has been recommended for approval by the CHMP as a treatment for hypercholesterolaemia or mixed dyslipidaemia, two common forms of elevated cholesterol linked to increased risk of cardiovascular disease.

article thumbnail

SparingVision raises €44.5m for retinitis pigmentosa gene therapy

pharmaphorum

French biotech SparingVision has raised 44.5 million euros ($52.7 million) to develop its gene therapy for a rare ocular disease. The round was led by 4BIO Capital and UPMC Enterprises with Jeito Capital and Ysios Capital joining. Current investors Bpifrance and Foundation Fighting Blindness also participated. In a statement, the company said funds will be used to further develop SparingVision’s SPVNo6, for treating all forms of the rare eye disease retinitis pigmentosa.

96
article thumbnail

Data hackathon analyses truth behind TB vaccine and COVID-19

pharmaphorum

Is a century-old vaccine a ‘game-changer’ for COVID-19? Anita de Waard from Elsevier and Radoslav Kirkov from Estafet tells us how a hackathon is harnessing data science to look beyond the hype and seek definitive clinical evidence. Today, the notion of ‘data science’ has permeated almost every area of society. Words like machine learning, artificial intelligence and deep learning have entered the everyday business lexicon.

article thumbnail

David Hung’s Nuvation Bio seals merger with blank cheque firm Panacea

pharmaphorum

Two years after quietly forming cancer start-up Nuvation Bio, ex-Axovant and Medivation CEO David Hung has agreed a big merger that will take it public – and provide more than $850 million in funding to boot. Hung’s new company is merging with Panacea Acquisition Corp, a special purpose acquisition company or SPAC – sometimes referred to as a ‘blank cheque’ company – tapping into an emerging trend among biotech companies.

71